v3.25.1
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning Balance, Shares at Dec. 31, 2023   204,084,024    
Beginning Balance at Dec. 31, 2023 $ 656,445 $ 204 $ 1,678,401 $ (1,022,160)
Exercise of stock options, Shares   493,608    
Exercise of stock options 3,168   3,168  
Issuance of common stock upon vesting of restricted stock units, shares   1,737,736    
Issuance of common stock upon vesting of restricted stock units   $ 2 (2)  
Stock-based compensation expense 10,766   10,766  
Stock-based compensation expense for Employee Stock Purchase Plan, or ESPP 193   193  
Net Income (Loss) (1,009)     (1,009)
Ending Balance, Shares at Mar. 31, 2024   206,315,368    
Ending Balance at Mar. 31, 2024 $ 669,563 $ 206 1,692,526 (1,023,169)
Beginning Balance, Shares at Dec. 31, 2024 204,335,860 204,335,860    
Beginning Balance at Dec. 31, 2024 $ 671,833 $ 204 1,685,644 (1,014,015)
Exercise of stock options, Shares 82,121 82,121    
Exercise of stock options $ 164   164  
Issuance of common stock upon vesting of restricted stock units, net of shares surrendered for taxes, shares   1,777,444    
Issuance of common stock upon vesting of restricted stock units, net of shares surrendered for taxes   $ 2 (2)  
Stock-based compensation expense 14,226   14,226  
Stock-based compensation expense for Employee Stock Purchase Plan, or ESPP 260   260  
Net Income (Loss) $ (7,311)     (7,311)
Ending Balance, Shares at Mar. 31, 2025 206,195,425 206,195,425    
Ending Balance at Mar. 31, 2025 $ 679,172 $ 206 $ 1,700,292 $ (1,021,326)